|
|
|
|
|
|
|
|
|
|
Previous: ICN PHARMACEUTICALS INC, 10-K/A, EX-23, 2000-07-07 |
Next: VOYAGEUR TAX EXEMPT TRUST SERIES 1, 497J, 2000-07-07 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM ICN
PHARMACEUTICALS, INC.'S DECEMBER 31, 1999 CONSOLIDATED FINANCIAL STATEMENTS AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-END> DEC-31-1999
<CASH> 177,577
<SECURITIES> 0
<RECEIVABLES> 258,449
<ALLOWANCES> (26,547)
<INVENTORY> 136,762
<CURRENT-ASSETS> 564,730
<PP&E> 409,482
<DEPRECIATION> (77,122)
<TOTAL-ASSETS> 1,472,261
<CURRENT-LIABILITIES> 140,622
<BONDS> 0
0
0
<COMMON> 789
<OTHER-SE> 682,783
<TOTAL-LIABILITY-AND-EQUITY> 1,472,261
<SALES> 638,475
<TOTAL-REVENUES> 747,412
<CGS> 256,146
<TOTAL-COSTS> 256,146
<OTHER-EXPENSES> 10,963
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 55,943
<INCOME-PRETAX> 139,985
<INCOME-TAX> 28,996
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 118,626
<EPS-BASIC> 1.52
<EPS-DILUTED> 1.45
</TABLE>
|
|